SCHEMBL570340

SCHEMBL570340

Brc1ccccc1N1CCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.48
MAPK1 P28482 2/20 0.47
HTR1A P08908 2/20 0.44
ADRA1B P35368 1/20 0.44
GAA P10253 2/20 0.44
MGLL Q99685 1/20 0.43
ALDH1A1 P00352 3/20 0.42
MAPT P10636 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
NPC1 O15118 2/20 0.41
NCF1 P14598 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.40
HTR6 P50406 1/20 0.40
EGFR P00533 1/20 0.40
RAF1 P04049 1/20 0.40
ALOX12 P18054 1/20 0.40
MAP2K1 Q02750 1/20 0.40
TDP1 Q9NUW8 1/20 0.38
ADRB1 P08588 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30263414 1.00 KEAP1 (0.48) KEAP1MAPK1HTR1AADRA1BGAA
SCHEMBL3975556 0.95 KEAP1 (0.54) KEAP1MAPK1HTR1AADRA1BGAA
SCHEMBL29763197 0.95 KEAP1 (0.54) KEAP1MAPK1HTR1AADRA1BGAA
SCHEMBL3021427 0.93 KEAP1 (0.57) KEAP1MAPK1HTR1AADRA1BGAA
SCHEMBL28534616 0.83 HTR7 (0.43) KEAP1MAPK1HTR1AGAAALDH1A1
SCHEMBL1929031 0.80 ADRA2C (0.60) MAPK1HTR1AADRA1BMAPTKMT2A
SCHEMBL10677139 0.80 HTR6 (0.62) HTR1AALDH1A1MAPTNCF1HTR6
SCHEMBL4753170 0.80 MGLL (0.39) KEAP1MAPK1HTR1AADRA1BGAA
SCHEMBL232830 0.80 HTR6 (0.62) HTR1AALDH1A1MAPTNCF1HTR6
SCHEMBL29446041 0.80 HTR6 (0.62) HTR1AALDH1A1MAPTNCF1HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140371464-A1 PROCESS FOR THE PREPARATION OF CHIRAL ISOXAZOLINE AZETIDINE DERIVATIVES AS ANTIPARASITIC AGENTS ZOETIS SERVICES LLC 2014-12-18 US claimed
EP-2809667-A1 PROCESS FOR THE PREPARATION OF CHIRAL ISOXAZOLINE AZETIDINE DERIVATIVES AS ANTIPARASITIC AGENTS Zoetis LLC (US) 2014-12-10 EP claimed
CN-104169276-A Process for the preparation of chiral isoxazoline azetidine derivatives as antiparasitic agents ZOETIS LLC 2014-11-26 CN claimed
WO-2013116236-A1 PROCESS FOR THE PREPARATION OF CHIRAL ISOXAZOLINE AZETIDINE DERIVATIVES AS ANTIPARASITIC AGENTS ZOETIS LLC (US) 2013-08-08 WO claimed
US-20230212131-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2023-07-06 US disclosed
US-20230212131-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2023-07-06 US disclosed
US-20230212131-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2023-07-06 US disclosed
EP-4161921-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF Anima Biotech Inc. (US) 2023-04-12 EP disclosed
CN-115916776-A Collagen 1 translation inhibitors and methods of use thereof 艾尼莫生物科技公司 2023-04-04 CN disclosed
WO-2021252555-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2021-12-16 WO disclosed
WO-2021252555-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2021-12-16 WO disclosed
EP-2601190-B1 ISOXAZOLINE DERIVATIVES AS ANTIPARASITIC AGENTS ZOETIS SERVICES LLC (US) 2018-07-04 EP disclosed
WO-2013169622-A1 AZETIDINE DERIVATIVES AS ANTIPARASITIC AGENTS ZOETIS LLC (US) 2013-11-14 WO disclosed
CN-103270036-A Isoxazoline derivatives as antiparasitic agents PFIZER 2013-08-28 CN disclosed
WO-2013116230-A1 DIHYDROFURAN AZETIDINE DERIVATIVES AS ANTIPARASITIC AGENTS ZOETIS LLC (US) 2013-08-08 WO disclosed
WO-2013116236-A1 PROCESS FOR THE PREPARATION OF CHIRAL ISOXAZOLINE AZETIDINE DERIVATIVES AS ANTIPARASITIC AGENTS ZOETIS LLC (US) 2013-08-08 WO disclosed
EP-2601190-A1 ISOXAZOLINE DERIVATIVES AS ANTIPARASITIC AGENTS AH USA 42 LLC (US) 2013-06-12 EP disclosed
US-8415310-B2 Isoxazoline derivatives as antiparasitic agents AH USA 42 LLC (US) 2013-04-09 US disclosed
WO-2012017359-A1 ISOXAZOLINE DERIVATIVES AS ANTIPARASITIC AGENTS PFIZER INC. (US) 2012-02-09 WO disclosed
US-20120035122-A1 ISOXAZOLINE DERIVATIVES AS ANTIPARASITIC AGENTS ZOETIS SERVICES LLC 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212131-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF COL1A1, COL2A1, COL14A1 KEAP1 1544/4885MAPK1 844/4885HTR1A 2470/4885
US-20120035122-A1 ISOXAZOLINE DERIVATIVES AS ANTIPARASITIC AGENTS ADORA1, CYP3A7, RDX KEAP1 3450/4885MAPK1 2282/4885HTR1A 215/4885
US-20140371464-A1 PROCESS FOR THE PREPARATION OF CHIRAL ISOXAZOLINE AZETIDINE DERIVATIVES AS ANTIPARASITIC AGENTS RDX, CYP2C9, CYP1A2 KEAP1 2244/4885MAPK1 2947/4885HTR1A 406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.